Final approval from the US Food and Drug Administration (“FDA”) for its Abbreviated New Drug Application (“ANDA”) for Guaifenesin Extended-Release Tablets, 600 mg and 1200 mg (OTC).
Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.
Disc: Invested. No Recommendation.
Subscribe To Our Free Newsletter |